-
1
-
-
33644516280
-
A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck
-
Budach W, Hehr T, Budach V, et al. A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck. BMC Cancer. 2006;6:28.
-
(2006)
BMC Cancer
, vol.6
, pp. 28
-
-
Budach, W.1
Hehr, T.2
Budach, V.3
-
2
-
-
33748169693
-
Adjuvant therapy in patients with resected poor-risk head and neck cancer
-
Bernier J, Vermorken JB, Koch WM. Adjuvant therapy in patients with resected poor-risk head and neck cancer. J Clin Oncol. 2006;24:2629-2635.
-
(2006)
J Clin Oncol
, vol.24
, pp. 2629-2635
-
-
Bernier, J.1
Vermorken, J.B.2
Koch, W.M.3
-
3
-
-
33646684021
-
Radiotherapy for head and neck cancer: Latest developments and future perspectives
-
Bernier J, Bentzen SM. Radiotherapy for head and neck cancer: latest developments and future perspectives. Curr Opin Oncol. 2006;18:240-246.
-
(2006)
Curr Opin Oncol
, vol.18
, pp. 240-246
-
-
Bernier, J.1
Bentzen, S.M.2
-
4
-
-
0027183870
-
Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer
-
Grandis JR, Tweardy DJ. Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer. Cancer Res. 1993;53:3579-3584.
-
(1993)
Cancer Res
, vol.53
, pp. 3579-3584
-
-
Grandis, J.R.1
Tweardy, D.J.2
-
5
-
-
30644478919
-
A phase II, open-label study of gefitinib (IRESSA) in patients with locally advanced, metastatic, or relapsed renal-cell carcinoma
-
Jermann M, Stahel RA, Salzberg M, et al. A phase II, open-label study of gefitinib (IRESSA) in patients with locally advanced, metastatic, or relapsed renal-cell carcinoma. Cancer Chemother Pharmacol. 2006;57:533-539.
-
(2006)
Cancer Chemother Pharmacol
, vol.57
, pp. 533-539
-
-
Jermann, M.1
Stahel, R.A.2
Salzberg, M.3
-
7
-
-
33646242760
-
Clinical experience with erlotinib in non-small-cell lung cancer
-
Felip E, Rosell R. Clinical experience with erlotinib in non-small-cell lung cancer. Drugs Today (Barc). 2006;42:147-156.
-
(2006)
Drugs Today (Barc)
, vol.42
, pp. 147-156
-
-
Felip, E.1
Rosell, R.2
-
8
-
-
29244448296
-
Radiation combined with EGFR signal inhibitors: Head and neck cancer focus
-
Harari PM, Huang S. Radiation combined with EGFR signal inhibitors: head and neck cancer focus. Semin Radiat Oncol. 2006;16:38-44.
-
(2006)
Semin Radiat Oncol
, vol.16
, pp. 38-44
-
-
Harari, P.M.1
Huang, S.2
-
9
-
-
31544433743
-
Epidermal growth factor receptor inhibitors in cancer treatment
-
Ciardiello F. Epidermal growth factor receptor inhibitors in cancer treatment. Future Oncol. 2005;1:221-234.
-
(2005)
Future Oncol
, vol.1
, pp. 221-234
-
-
Ciardiello, F.1
-
10
-
-
31444441698
-
Targeting the epidermal growth factor receptor (EGFR) - a new therapeutic option in oncology?
-
Mamot C, Rochlitz C. Targeting the epidermal growth factor receptor (EGFR) - a new therapeutic option in oncology? Swiss Med Wkly. 2006;136:4-12.
-
(2006)
Swiss Med Wkly
, vol.136
, pp. 4-12
-
-
Mamot, C.1
Rochlitz, C.2
-
11
-
-
33645017703
-
Optimizing chemotherapy and targeted agent combinations in NSCLC
-
Lynch T Jr, Kim E. Optimizing chemotherapy and targeted agent combinations in NSCLC. Lung Cancer. 2005;50(suppl 2):S25-S32.
-
(2005)
Lung Cancer
, vol.50
, Issue.SUPPL. 2
-
-
Lynch Jr, T.1
Kim, E.2
-
12
-
-
33645542766
-
Palliative chemotherapy of head and neck cancer: Present status and future development
-
Hennemann B. Palliative chemotherapy of head and neck cancer: present status and future development. Laryngorhinootologie. 2006;85:172-178.
-
(2006)
Laryngorhinootologie
, vol.85
, pp. 172-178
-
-
Hennemann, B.1
-
13
-
-
33645101097
-
Epidermal growth factor receptor mutations in non-small cell lung cancer: A basic science discovery with immediate clinical impact
-
Dowell JE. Epidermal growth factor receptor mutations in non-small cell lung cancer: a basic science discovery with immediate clinical impact. Am J Med Sci. 2006;331:139-149.
-
(2006)
Am J Med Sci
, vol.331
, pp. 139-149
-
-
Dowell, J.E.1
-
14
-
-
31544436908
-
Oral complications of radiotherapy
-
Sciubba JJ, Goldenberg D. Oral complications of radiotherapy. Lancet Oncol. 2006;7:175-183.
-
(2006)
Lancet Oncol
, vol.7
, pp. 175-183
-
-
Sciubba, J.J.1
Goldenberg, D.2
-
15
-
-
0033780559
-
Prevention and management of mucositis in patients with cancer
-
Herrstedt J. Prevention and management of mucositis in patients with cancer. Int J Antimicrob Agents. 2000;16:161-163.
-
(2000)
Int J Antimicrob Agents
, vol.16
, pp. 161-163
-
-
Herrstedt, J.1
-
16
-
-
33645515321
-
Burning mouth syndrome: Clinical presentation, diagnosis and treatment
-
quiz, 82-73
-
Savage NW, Boras W, Barker K. Burning mouth syndrome: clinical presentation, diagnosis and treatment. Australas J Dermatol. 2006;47:77-81; quiz, 82-73.
-
(2006)
Australas J Dermatol
, vol.47
, pp. 77-81
-
-
Savage, N.W.1
Boras, W.2
Barker, K.3
-
17
-
-
0018102126
-
Psychological aspects of glossodynia (author's transl)
-
Haneke E. Psychological aspects of glossodynia (author's transl). Dtsch Med Wochenschr. 1978;103:1302-1305.
-
(1978)
Dtsch Med Wochenschr
, vol.103
, pp. 1302-1305
-
-
Haneke, E.1
-
19
-
-
14744271430
-
Hypersensitivity reactions to oxaliplatin: Incidence and management
-
1675; discussion, 1680
-
Gowda A, Goel R, Berdzik J, et al. Hypersensitivity reactions to oxaliplatin: incidence and management. Oncology (Williston Park). 2004;18:1671-1675; discussion, 1676, 1680, 1683-1684.
-
(1676)
Oncology (Williston Park)
, vol.18
-
-
Gowda, A.1
Goel, R.2
Berdzik, J.3
-
20
-
-
0031035115
-
Palmar-plantar erythrodysaesthesia syndrome and other cutaneous side-effects after treatment with Tegafur
-
Rios-Buceta L, Buezo GF, Penas PF, et al. Palmar-plantar erythrodysaesthesia syndrome and other cutaneous side-effects after treatment with Tegafur. Acta Derm Venereol. 1997;77:80-81.
-
(1997)
Acta Derm Venereol
, vol.77
, pp. 80-81
-
-
Rios-Buceta, L.1
Buezo, G.F.2
Penas, P.F.3
-
21
-
-
33750991326
-
Phase II study of oxaliplatin as second-line chemotherapy in endometrial carcinoma: A gynecologic oncology group study
-
Fracasso PM, Blessing JA, Molpus KL, et al. Phase II study of oxaliplatin as second-line chemotherapy in endometrial carcinoma: a gynecologic oncology group study. Gynecol Oncol. 2006;103:523-526.
-
(2006)
Gynecol Oncol
, vol.103
, pp. 523-526
-
-
Fracasso, P.M.1
Blessing, J.A.2
Molpus, K.L.3
-
22
-
-
0030742933
-
Radiotherapy and concomitant weekly 1-hour infusion of paclitaxel in the treatment of head and neck cancer-results from a phase I trial
-
Hoffmann W, Belka C, Schmidberger H, et al. Radiotherapy and concomitant weekly 1-hour infusion of paclitaxel in the treatment of head and neck cancer-results from a phase I trial. Int J Radiat Oncol Biol Phys. 1997;38:691-696.
-
(1997)
Int J Radiat Oncol Biol Phys
, vol.38
, pp. 691-696
-
-
Hoffmann, W.1
Belka, C.2
Schmidberger, H.3
-
23
-
-
0031475070
-
A phase I trial of radiotherapy and simultaneous 24-hour paclitaxel in patients with locally advanced head and neck squamous cell carcinoma
-
Steinberg L, Hassan M, Olmsted L, et al. A phase I trial of radiotherapy and simultaneous 24-hour paclitaxel in patients with locally advanced head and neck squamous cell carcinoma. Semin Oncol. 1997;24(suppl 19):51-56.
-
(1997)
Semin Oncol
, vol.24
, Issue.SUPPL. 19
, pp. 51-56
-
-
Steinberg, L.1
Hassan, M.2
Olmsted, L.3
-
24
-
-
10644261471
-
Overview of the tolerability of gefitinib (IRESSA) monotherapy: Clinical experience in non-small-cell lung cancer
-
Forsythe B, Faulkner K. Overview of the tolerability of gefitinib (IRESSA) monotherapy: clinical experience in non-small-cell lung cancer. Drug Saf. 2004;27:1081-1092.
-
(2004)
Drug Saf
, vol.27
, pp. 1081-1092
-
-
Forsythe, B.1
Faulkner, K.2
-
25
-
-
24744469035
-
Gefitinib in patients with advanced non-small cell lung cancer (NSCLC): The expanded access protocol experience at the University of Pennsylvania
-
Veronese ML, Algazy K, Bearn L, et al. Gefitinib in patients with advanced non-small cell lung cancer (NSCLC): the expanded access protocol experience at the University of Pennsylvania. Cancer Invest. 2005;23:296-302.
-
(2005)
Cancer Invest
, vol.23
, pp. 296-302
-
-
Veronese, M.L.1
Algazy, K.2
Bearn, L.3
-
26
-
-
21044438337
-
Paclitaxel and carboplatin as first-line chemotherapy combined with gefitinib (IRESSA) in patients with advanced breast cancer: A phase I/II study conducted by the Hellenic Cooperative Oncology Group
-
Fountzilas G, Pectasides D, Kalogera-Fountzila A, et al. Paclitaxel and carboplatin as first-line chemotherapy combined with gefitinib (IRESSA) in patients with advanced breast cancer: a phase I/II study conducted by the Hellenic Cooperative Oncology Group. Breast Cancer Res Treat. 2005;92:1-9.
-
(2005)
Breast Cancer Res Treat
, vol.92
, pp. 1-9
-
-
Fountzilas, G.1
Pectasides, D.2
Kalogera-Fountzila, A.3
-
27
-
-
33644848522
-
Increased toxicity with gefitinib, capecitabine, and radiation therapy in pancreatic and rectal cancer: Phase I trial results
-
Czito BG, Willett CG, Bendell JC, et al. Increased toxicity with gefitinib, capecitabine, and radiation therapy in pancreatic and rectal cancer: phase I trial results. J Clin Oncol. 2006;24:656-662.
-
(2006)
J Clin Oncol
, vol.24
, pp. 656-662
-
-
Czito, B.G.1
Willett, C.G.2
Bendell, J.C.3
-
28
-
-
32144433159
-
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck
-
Bonner JA, Harari PM, Giralt J, et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med. 2006;354:567-578,
-
(2006)
N Engl J Med
, vol.354
, pp. 567-578
-
-
Bonner, J.A.1
Harari, P.M.2
Giralt, J.3
-
29
-
-
28744451855
-
Neuropathic pain due to malignancy: Mechanisms, clinical manifestations and therapy
-
Pjevic M, Patarica-Huber E, Radovanovic D, et al. Neuropathic pain due to malignancy: mechanisms, clinical manifestations and therapy. Med Pregl. 2004;57:33-40.
-
(2004)
Med Pregl
, vol.57
, pp. 33-40
-
-
Pjevic, M.1
Patarica-Huber, E.2
Radovanovic, D.3
-
30
-
-
0036366760
-
Anticonvulsants in neuropathic pain: Rationale and clinical evidence
-
Jensen T. Anticonvulsants in neuropathic pain: rationale and clinical evidence. Eur J Pain. 2002;6:61-68.
-
(2002)
Eur J Pain
, vol.6
, pp. 61-68
-
-
Jensen, T.1
-
31
-
-
33745947782
-
Mechanisms of the antinociceptive action of gabapentin
-
Cheng JK, Chiou LC. Mechanisms of the antinociceptive action of gabapentin. J Pharmacol Sci. 2006;100:471-486.
-
(2006)
J Pharmacol Sci
, vol.100
, pp. 471-486
-
-
Cheng, J.K.1
Chiou, L.C.2
-
32
-
-
33747171616
-
Gabapentin and pregabalin for the treatment of neuropathic pain: A review of laboratory and clinical evidence
-
Gilron I, Flatters S. Gabapentin and pregabalin for the treatment of neuropathic pain: a review of laboratory and clinical evidence. Pain Res Manag. 2006;11:16A-29A.
-
(2006)
Pain Res Manag
, vol.11
-
-
Gilron, I.1
Flatters, S.2
-
33
-
-
58149254915
-
Gabapentin for the treatment of pain related to radiation-induced mucositis, in patients with head and neck cancers treated with concurrent chemoradiation using intensity modulated radiation therapy (IMRT)
-
Bar Ad V, Dutta P, Both S, et al. Gabapentin for the treatment of pain related to radiation-induced mucositis, in patients with head and neck cancers treated with concurrent chemoradiation using intensity modulated radiation therapy (IMRT). Int J Radiat Oncol Biol Phys. 2007;69:S426-S427.
-
(2007)
Int J Radiat Oncol Biol Phys
, vol.69
-
-
Bar, A.V.1
Dutta, P.2
Both, S.3
-
34
-
-
0035855860
-
Molecular mechanisms of nociception
-
Julius D, Basbaum AI. Molecular mechanisms of nociception. Nature. 2001;413:203-210.
-
(2001)
Nature
, vol.413
, pp. 203-210
-
-
Julius, D.1
Basbaum, A.I.2
-
35
-
-
0034625770
-
Neuronal plasticity: Increasing the gain in pain
-
Woolf CJ, Salter MW. Neuronal plasticity: increasing the gain in pain. Science. 2000;288:1765-1769.
-
(2000)
Science
, vol.288
, pp. 1765-1769
-
-
Woolf, C.J.1
Salter, M.W.2
-
36
-
-
33644765967
-
Optical coherence tomography reveals in vivo cortical plasticity of adult mice in response to peripheral neuropathic pain
-
Ooi Y, Satomura Y, Seki J, et al. Optical coherence tomography reveals in vivo cortical plasticity of adult mice in response to peripheral neuropathic pain. Neurosci Lett. 2006;397:35-39.
-
(2006)
Neurosci Lett
, vol.397
, pp. 35-39
-
-
Ooi, Y.1
Satomura, Y.2
Seki, J.3
|